Women’s Health Market Size, Share & Trends Report

Women’s Health Market Size, Share & Trends Analysis By Application (Postmenopausal Osteoporosis, Infertility, Endometriosis, Contraceptives, Menopause, PCOS), By Region, And Segment Forecasts, 2019 - 2026

  • Published Date: Aug, 2019
  • Base Year for Estimate: 2018
  • Report ID: GVR-1-68038-634-9
  • Format: Electronic (PDF)
  • Historical Data: 2015 - 2018
  • Number of Pages: 130

Industry Insights

The global women’s health market size was valued at USD 39.3 billion in 2018 and is expected to grow at a CAGR of 4.2% over the forecast period. Increase in population of geriatric women, rise in adoption of an unhealthy lifestyle, and introduction of novel medicines for women can be attributed to the market growth. Furthermore, favorable policies initiated by the government to improve women’s health and raise awareness are likely to propel the market growth during the forecast period. Women are at a higher risk of diseases such as osteoporosis, osteoarthritis, anemia, menstrual health-related disorders, depression, and obesity. Hence, increasing incidence of these conditions is likely to boost the market growth in the coming years.

According to WHO, the health status of women is usually poor. Women are susceptible to some diseases, particularly after menopause, such as Osteoarthritis (OA), osteoporosis, anemia, obesity, menstrual health disorders, depression, and fibromyalgia. Furthermore, cardiovascular diseases, breast cancer, lung cancer, and mental health are the major conditions that generate the majority of the burden in non-communicable diseases. Around 73% of postmenopausal women experience hot flashes, wherein the associated fatigue and sleep disturbances increase dependence on medications, impairing the quality of life.

U.S. Women’s Health market

Changes in dietary habits, stress, and consumption of alcohol are the key factors responsible for hormonal imbalance among women. This is likely to cause fertility issues in women. Ovulation problems, endometriosis, and Polycystic Ovarian Syndrome (PCOS) are the major known factors for infertility. According to the CDC, about 10% of women (6.1 million) in the U.S., aged 15 to 44 years have difficulty in getting pregnant. Hence, all these factors are likely to aid in the growth of the market globally.

Government and various private organizations are focused on women health across the globe, which is likely to drive the market in the coming years. Coverage provided to women is one of the key factors expected to drive the market in developed countries. For instance, various coverage plans in the U.S. provide preventive services for women without any copayment charges. This includes anemia screening on a routine basis, folic acid supplements for women who may become pregnant, hepatitis B screening, breast cancer screening, contraception, and many others. Healthy People 2020 was established by the Department of Health and Human Services to improve the health of all Americans in 10 years.

Application Insights

On the basis of application, the women’s health market has been segmented into postmenopausal osteoporosis, hormonal infertility, endometriosis, contraceptives, menopause, and Polycystic Ovary Syndrome (PCOS). In 2018, postmenopausal osteoporosis segment accounted for the largest share of the market due to an increasing population of elderly women aged 40 and above, and introduction of various drugs to treat menopausal osteoporosis.

Presence of various major market players and ongoing R&D are factors likely to drive the segment during the forecast period. However, contraceptives segment is likely to witness the fastest growth during the forecast period. This can be attributed to the increasing use of contraceptives due to more awareness and entry of various products including patches and vaginal rings. Furthermore, global market of major products such as Evista, XGEVA, Mirena, Zometa, Minastrin 24FE, Nuvaring, Forteo, Premarin, Actonel, Ortho-Tri-Cy LO 28, and Reclast are incorporated in the report.

Hormonal infertility segment observed a strong growth after contraceptives due to high fertility related disorders in developed countries. Furthermore, the availability of several medicines to treat hormonal imbalance and market players’ investment in the segment is likely to improve the penetration of the segment in the coming years. Hormonal imbalance such as the imbalance of thyroid, Prolactin, estrogen is growing in women due to stress in life drive the growth of the market.

Regional Insights

North America held the largest share of the global market in 2018. Presence of key market players, supportive government regulations, favorable reimbursement, approval & commercialization of products, and growing awareness about women’s health are the key factors for the dominance of the market.

Women’s Health market

The Asia Pacific region is estimated to grow at the fastest rate during the forecast period. This can be attributed to increasing awareness about women’s health, rising incidence of osteoarthritis, infertility, and other women-related disorders due to stress, and government initiatives for reimbursement and raising awareness.

Women’s Health Market Share Insights

Some of the key players operating in the women’s health market include Allergan; Bayer AG; Merck & Co., Inc.; Pfizer; Teva Pharmaceuticals; Agile Therapeutics; Amgen, Inc.; AstraZeneca, Bristol-Myers Squibb, Ferring B.V. Collaborations for development, expansion of product portfolios, and regional expansion in emerging markets are the key strategic undertakings of these companies to increase market share.

Market players apply a fresh FDA approval request for new indications in order to prevent loss in revenues post patent expiry. For instance, Prolia is recommended for postmenopausal women who are susceptible to bone fractures due to osteoporosis. The indications differ according to the approvals across various geographies. For instance, in the U.S., it is majorly used as a second or third line of treatment for women who have suffered at least one or multiple osteoporotic fractures. In Europe, it is prescribed for women with a high risk of osteoporotic fractures and as a treatment of osteoporosis.

Report Scope

Attribute

Details

Base year for estimation

2018

Actual estimates/Historic data

2015 - 2018

Forecast period

2019 - 2026

Market representation

Revenue in USD Billion & CAGR from 2019 to 2026

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Country scope

U.S., Canada, UK, Germany, Japan, China, Brazil, Mexico, South Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors & trends

15% free customization scope (equivalent to 5 analyst working days)

If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization


Segments Covered in the Report

This report forecasts revenue growth and provides an analysis on the latest trends in each of the subsegments from 2015 to 2026. For this study, Grand View Research has segmented the women’s health market based on application and region:

  • Application Outlook (Revenue, USD Million; 2015 - 2026)

    • Postmenopausal Osteoporosis

    • Hormonal Infertility

    • Endometriosis

    • Contraceptives

    • Menopause

    • Polycystic Ovary Syndrome

  • Regional Outlook (Revenue, USD Million, 2015 - 2026)

    • North America

      • U.S.

      • Canada

    • Europe

      • UK

      • Germany

    • Asia Pacific

      • Japan

      • China

    • Latin America

      • Brazil

      • Mexico

    • Middle East & Africa

      • South Africa

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $5,950
Multi User (2-5) - $6,950
Enterprise Access - $8,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified